📰 Wang Chen News
Page 7 - Wang Chen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Wang Chen. Real-time updates on events, politics, business and more.
March 1, 2023
BEIJING, March 1 (Xinhua) -- The Communist Party of China (CPC) Central Committee held a consultative meeting on Tuesday at Zhongnanhai in Beijing with the cent
February 28, 2023
Original title: Inform the representatives of the Central All-China Federation of Industry and Commerce of the democratic parties and people without party affiliation on the situation and listen to opinions The Central Committee of the Communist Party of China Holds a Democratic Consultative Conference Xi Jinping presided over and delivered an important speech Li Qiang Zhao Leji Wang Huning Cai
February 21, 2023
The landscape for Chinese securities firms is set to be reshaped as a registration-based initial public offering system is expected to be more widely adopted and extended to the A-share main board, where more large-caps and industry juggernauts are listed, industry experts said.
February 20, 2023
Senior lawmaker stresses need to adhere to socialist rule of law with Chinese characteristics-
February 17, 2023
Chamber Orchestra of the Springs will celebrate its 40th anniversary with the beginning of its new season in September.
February 4, 2023
Rotary phones, floppy disks, CDs and cassette tapes, pagers, VHS, typewriters — the list goes on. These are all examples of obsolete technologies that have since been phased out as
December 30, 2022
BEIJING, Dec. 30 (Xinhua) -- The Standing Committee of the 13th National People Congress (NPC) concluded its 38th session Friday in Beijing. At the closing meet
December 30, 2022
Roundup: Chinas top legislature concludes standing committee session-
December 22, 2022
Startups founded by MIT-educated mechanical engineers are at the forefront of developing solutions to mitigate the environmental impact of manufacturing.
December 20, 2022
/PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK) announced today that, XIANNUOXIN (SIM0417), an anti-SARS-CoV-2 drug candidate jointly developed by...